Examples
The different types of insulin are categorized according to how fast they start to work (onset) and how long they continue to work (duration). The types now available include rapid-, short-, intermediate-, and long-acting insulin.
Rapid-acting
| Brand Name | Chemical Name |
| NovoLog | insulin aspart |
| Apidra | insulin glulisine |
| Humalog | insulin lispro |
| Humulin-R | insulin regular |
| Humulin-N | insulin NPH |
| Levemir | insulin detemir |
| Lantus | insulin glargine |
Short-acting
| Brand Name | Chemical Name |
| NovoLog | insulin aspart |
| Apidra | insulin glulisine |
| Humalog | insulin lispro |
| Humulin-R | insulin regular |
| Humulin-N | insulin NPH |
| Levemir | insulin detemir |
| Lantus | insulin glargine |
Intermediate-acting
| Brand Name | Chemical Name |
| NovoLog | insulin aspart |
| Apidra | insulin glulisine |
| Humalog | insulin lispro |
| Humulin-R | insulin regular |
| Humulin-N | insulin NPH |
| Levemir | insulin detemir |
| Lantus | insulin glargine |
Long-acting
| Brand Name | Chemical Name |
| NovoLog | insulin aspart |
| Apidra | insulin glulisine |
| Humalog | insulin lispro |
| Humulin-R | insulin regular |
| Humulin-N | insulin NPH |
| Levemir | insulin detemir |
| Lantus | insulin glargine |
There are premixed rapid- and intermediate-acting insulins available, including:
- 70% intermediate-acting (NPH) and 30% short-acting regular insulin, called 70/30 insulin.
- 50% intermediate-acting (NPH) and 50% short-acting regular insulin, called 50/50 insulin.
- 75% intermediate-acting and 25% rapid-acting Humalog (lispro), called 75/25 insulin.
- 70% intermediate-acting and 30% rapid-acting NovoLog (insulin aspart), called NovoLog Mix 70/30.
Packaging
Injectable insulin is packaged in small glass vials (bottles) and cartridges that hold more than one dose and are sealed with rubber lids. The cartridges are used in pen-shaped devices called insulin pens.
How insulin is taken
Insulin usually is given as an injection into the tissues under the skin (subcutaneous). It can also be given through an insulin pump, an insulin pen, or jet injector, a device that sprays the medication into the skin. Some insulins can be given through a vein (only in a hospital).
Research is ongoing to develop new forms of insulin, as well as insulin that can be taken in other ways, such as by mouth or nasal spray.
How It Works
Insulin lets sugar (glucose) in the blood enter cells, where it is used for energy. Without insulin, the blood sugar level rises above what is safe for the body.
Your body uses insulin in different ways. Sometimes you need insulin to work quickly to reduce blood sugar. Your body also needs insulin on a regular basis to keep your blood sugar within a normal or near normal range.
- Rapid-acting and short-acting insulins reduce blood sugar levels quickly and then wear off.
- When you use long-acting insulin with rapid- or short-acting insulins, the long-acting insulin starts taking effect when rapid- or short-acting insulins begin to wear off. The long-acting insulin glargine (Lantus) starts to work within an hour after it is given and continues to work at the same rate for about 24 hours. Lantus cannot be mixed in the same syringe with other types of insulin.
- Usually people who take insulin use a combination of a rapid- or short-acting and an intermediate- or long-acting insulin. This helps keep blood sugar levels within a range that is safe for the body throughout the day.
Why It Is Used
Insulin is used to treat:
- People with type 1 diabetes.
- People with type 2 diabetes whose pancreas produces little or no insulin or whose oral medications do not control their blood sugar. These people may take insulin either alone or along with oral medication.
- People with type 2 diabetes whose blood sugar levels are high because of a severe illness or major surgery. After blood sugar levels return to a target range, these people may be able to stop taking insulin.
- Women with type 2 diabetes who are pregnant or breast-feeding who cannot keep their blood sugar levels within a target range with diet and exercise. Only one oral diabetes medication (glyburide) has been studied for use during pregnancy. Until further research is done, the American Diabetes Association recommends that pregnant women and women who are breast-feeding not take oral diabetes medications.
How Well It Works
Insulin is effective in reducing blood sugar levels by helping sugar (glucose) enter the cells to be used for energy.
For people with type 1 diabetes
Results of the 10-year Diabetes Control and Complications Trial (DCCT) and the follow-up Epidemiology of Diabetes Interventions and Complications (EDIC) study showed that people with type 1 diabetes who kept their blood sugar levels tightly within a normal or near-normal range (tightly controlled therapy) had fewer incidences of eye, kidney, and nerve damage from diabetes than people who were on standard therapy. Tightly controlled therapy also lowered the risk of heart attacks and deaths from heart disease.1
One study shows that insulin glargine (Lantus) is as effective as NPH insulin in controlling blood sugar in people with type 1 diabetes. Lantus causes fewer low blood sugar episodes than NPH.2
For people with type 2 diabetes
Results of the United Kingdom Prospective Diabetes Study (UKPDS) showed that insulin decreased the risk of diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy in people with type 2 diabetes.
Side Effects
The major side effect of insulin can be a dangerously low blood sugar level (severe hypoglycemia). A very low blood sugar level can develop within 10 to 15 minutes with rapid-acting insulins.
Insulin can contribute to weight gain, especially in people with type 2 diabetes who already are overweight.
Other possible side effects of long-term insulin use include the loss of fatty tissue (lipodystrophy) where the insulin is injected and, rarely, allergic reactions that include swelling, or edema.
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
What To Think About
People with type 1 diabetes who tightly control their blood sugar levels using either multiple daily injections or the insulin pump have lower hemoglobin A1c levels and may reduce their risk for developing small blood vessel complications (eye and kidney disease) compared to people who take one or two injections every day.3
The insulin pump provides a way to give insulin with less frequent injections and is as effective as multiple daily injections at keeping blood sugar levels within a target range.
The long-acting insulin glargine (Lantus) may help prevent some people from having frequent nighttime low blood sugar levels. It may also be helpful for people who have had difficulty keeping their blood sugar levels within their target range with intermediate-acting insulin.
The rapid-acting insulins, Apidra (glulisine), Humalog (lispro), and NovoLog (insulin aspart), can be given with a meal or immediately afterward. This may help you keep your blood sugar levels within your target range when you eat something not on your daily meal plan.3
Giving short-acting insulin at the evening meal and NPH at bedtime instead of giving them together at the evening meal may reduce the risk of nocturnal hypoglycemia and hypoglycemia unawareness.4
What can affect insulin
Some factors that affect how fast and how well an insulin dose works include:
- Where the dose is given. If you give insulin into your abdomen (especially above and to the side of your belly button), the medication will get into your system more consistently from day to day. If the medication is given into a muscle or a small blood vessel instead of fatty tissue, the medication will get into your system faster.
- How much insulin is given. Higher doses of insulin reduce the blood sugar level more than lower doses.
- Whether you have exercised before or just after taking insulin. If you have just exercised the muscles in the area where you give your insulin injection, the medication will get into your system faster.
- If you apply heat to the area. The medication will get into your system more quickly if you take a hot bath or shower, put on a heat pack, or massage the area where you have just given your insulin injection.
- If you do not have enough fluid in your body (you are dehydrated), you will not have as much blood flow to your skin; insulin will not be absorbed as well as it would otherwise.
Things to do
- Label each insulin bottle when it is used for the first time, and discard unused medication after 30 days. A bottle of insulin may lose its ability to work well (potency) after 30 days of use.
- Store insulin properly so that its effectiveness is protected.
- When you buy insulin, check the generic or brand names to make sure you are buying the correct type. For example, if you have been using Humulin-R (insulin regular), make sure you buy Humulin-R instead of Humulin-N (insulin NPH).
- Know when your prescribed types of insulin start working (onset), when they work most (peak), and how long they work (duration).
- Know how to give an insulin injection.
Precautions to take with long-acting insulin
The long-acting insulin glargine (Lantus):
- Should be used only if it is clear, colorless, and contains no particles.
- Should not be given using a syringe that has been used to give another type of insulin.
- Should not be mixed with any other type of insulin. People who cannot take multiple injections may not be able to take this medication.
- Should be clearly labeled so it is not confused with short-acting insulins, which also are clear.
- Usually is injected as one dose at bedtime; however, it can be taken in the morning and it can be split into morning and evening doses.
- May cause more discomfort at the injection site than other types of insulin because it is acidic.
- Should not be used in an insulin pump.
Children with type 2 diabetes
Insulin may be given as a single nighttime dose or as several smaller doses throughout the day.
Complete the new medication information form (PDF)
(What is a PDF document?) to help you understand this medication.
References
Citations
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group (2005). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New England Journal of Medicine, 353(25): 2634–2653.
Ratner RE, et al. (2000). Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care, 23(5): 639–643.
Cheng AYY, Zinman B (2001). Insulin for treating type 1 and type 2 diabetes. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 323–343. Hamilton, ON: BC Decker.
Fanelli CG, et al. (2002). Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. Annals of Internal Medicine, 136(7): 504–514.
Credits
| Author | Robin Parks, MS |
| Editor | Kathleen M. Ariss, MS |
| Associate Editor | Denele Ivins |
| Associate Editor | Pat Truman |
| Primary Medical Reviewer | Caroline S. Rhoads, MD - Internal Medicine |
| Specialist Medical Reviewer | Matthew I. Kim, MD - Endocrinology & Metabolism |
| Last Updated | January 15, 2007 |
© 1995-2007, Healthwise, Incorporated, P.O. Box 1989, Boise, ID 83701. ALL RIGHTS RESERVED.
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information. For more information, click here. Privacy Policy. How this information was developed.

